{{cart_num}}
My Cart> Small Molecule Compounds > Inhibitors & Antagonists & Agonists > NF-κB > Usnic acidCAS：125-46-2
Storage：Powder:2-8℃，2 years;Insolvent(Mother Liquid):-20℃，6 months;-80℃，1 year
Purity：HPLC≥98%
Appearance：Light yellow to yellow Solid
Qty：
Size：
| CAS | 125-46-2 |
| Name | Usnic acid |
| Molecular Formula | C18H16O7 |
| Molecular Weight | 344.32 |
| Solubility | Soluble in DMSO ≥2.5mg/mL |
| Purity | HPLC≥98% |
| Appearance | Light yellow to yellow Solid |
| Storage | Powder:2-8℃，2 years;Insolvent(Mother Liquid):-20℃，6 months;-80℃，1 year |
| EC | EINECS 231-456-0 |
| MDL | MFCD00065294 |
| SMILES | O=C(C1(C)C(OC2=C(C(C)=O)C(O)=C(C)C(O)=C12)=C3)C(C(C)=O)C3=O |
| InChIKey | CUCUKLJLRRAKFN-UHFFFAOYSA-N |
| InChI | InChI=1S/C18H16O7/c1-6-14(22)12(8(3)20)16-13(15(6)23)18(4)10(25-16)5-9(21)11(7(2)19)17(18)24/h5,11,22-23H,1-4H3 |
| PubChem CID | 5646 |
| Target Point | Osteoclast；RANKL/RANK |
| Passage | Immunology & Inflammation；NF-kB |
| Background | Usnic acid has excellent anticancer and antimicrobial properties. It has been reported that Usnic acid can significantly inhibit RANKL-mediated osteoclast formation and function by reducing the transcriptional and translational expression of NFATc1. ) |
| Unit | Piece |
| Specification | 10mg 20mg 50mg |
Remark：These protocols are for reference only. Solarbio does not independently validate these methods.
Note：
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Sorry, there is no more information.
Sorry, there is no more information.
Manual Download
